Yahoo Web Search

Search results

1. • 

     Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication

     Zacks via Yahoo Finance· 1 year ago

     The FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for...

2. • 

     Roche (RHHBY) Actemra Gets FDA Nod for Adults With COVID-19

     Zacks via Yahoo Finance· 1 year ago

     Roche (RHHBY) obtains FDA approval for Actemra (tocilizumab) intravenous (IV) for the treatment of...

3. • 

     Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag

     Zacks via Yahoo Finance· 4 days ago

     The FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for...

4. • 

     Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion

     Zacks via Yahoo Finance· 1 month ago

     Roche (RHHBY) has won FDA approval for Alecensa as an adjuvant treatment, following tumor resection...

5. • 

     Roche (RHHBY) Influenza Drug Gets FDA Nod for Children

     Zacks via Yahoo Finance· 2 years ago

     Roche RHHBY recently announced that the FDA has approved a label expansion of its influenza drug for...

6. • 

     Roche's (RHHBY) Application for PNH Drug Accepted by FDA

     Zacks via Yahoo Finance· 9 months ago

     Roche Group RHHBY member Genentech has received a significant boost following the acceptance of its...

7. • 

     Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation

     Zacks via Yahoo Finance· 2 weeks ago

     Roche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...

8. • 

     Here's Why You May Invest in Puma Biotechnology (PBYI) Stock

     Zacks via Yahoo Finance· 6 months ago

     Puma Biotechnology, Inc.PBYI is a biotechnology company focused on research in cancer. The company’s...

9. • 

     Roche's (RHHBY) Xolair Gets Approval for Food Allergies

     Zacks via Yahoo Finance· 3 months ago

     Roche RHHBY announced that the FDA has approved a label expansion of the asthma drug Xolair...

10. • 

      Will Seagen's (SGEN) Portfolio of Drugs Help Combat Rivalry?

      Zacks via Yahoo Finance· 2 years ago

      Seagen (SGEN) expects its portfolio of marketed drugs, which are approved for various cancer...